Niagen Bioscience (NAGE) EBITDA (2010 - 2026)
Niagen Bioscience (NAGE) reported EBITDA of $1.6 million for Q1 2026, down 66.97% year-over-year from $4.8 million in Q1 2025, and down 61.43% quarter-over-quarter from $4.1 million in Q4 2025.
Niagen Bioscience (NAGE) EBITDA (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 17 years of EBITDA data on file, last reported at $1.6 million in Q1 2026.
- EBITDA for Q1 2026 came in at $1.6 million, down 66.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.1 million (down 1.1% YoY), and the FY2025 annual result was $16.3 million, up 110.7% from the prior year.
- EBITDA slipped to $1.6 million in Q1 2026 per NAGE's latest filing, from $4.1 million in the prior quarter.
- Over five years, EBITDA peaked at $7.1 million in Q4 2024 and troughed at -$7.7 million in Q1 2022.
- A 5-year average of $79647.1 and a median of -$256000.0 in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2024 and 2026: EBITDA jumped 4332.74% in 2024, then plunged 66.97% in 2026.
- A 5-year view of EBITDA shows it stood at -$1.4 million in 2022, then surged by 88.37% to -$168000.0 in 2023, then jumped by 4332.74% to $7.1 million in 2024, then tumbled by 42.54% to $4.1 million in 2025, then sank by 61.43% to $1.6 million in 2026.
- Business Quant data shows NAGE's EBITDA at $1.6 million in Q1 2026, $4.1 million in Q4 2025, and $4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 4.09 Mn |
| Sep 30, 2025 | 4.24 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Dec 31, 2024 | 7.11 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | -256,000.00 |
| Mar 31, 2024 | -731,000.00 |
| Dec 31, 2023 | -168,000.00 |
| Sep 30, 2023 | -1.15 Mn |
| Jun 30, 2023 | -2.32 Mn |
| Mar 31, 2023 | -1.97 Mn |
| Dec 31, 2022 | -1.44 Mn |
| Sep 30, 2022 | -3.07 Mn |
| Jun 30, 2022 | -6.39 Mn |
| Mar 31, 2022 | -7.73 Mn |
| Dec 31, 2021 | -5.32 Mn |
| Sep 30, 2021 | -8.84 Mn |
| Jun 30, 2021 | -5.55 Mn |